A novel synthetic, nonpsychoactive cannabinoid acid (HU‐320) with antiinflammatory properties in murine collagen‐induced arthritis

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R., Weaver, A. L., Ettlinger, R. E., Cohen, S. B., Koopman, W. J., Mohler, K. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,620

Etanercept Therapy in Rheumatoid Arthritis

Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,403

Rheumatoid arthritis

Lee, D. M., & Weinblatt, M. E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06075-5 · Cited by 1,328

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315

Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?

Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,252

Use of MTT colorimetric assay to measure cell activation

Gerlier, D., & Thomasset, N. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90215-2 · Cited by 1,203

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P. J., Katsikis, P. D., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038

Immunisation against heterologous type II collagen induces arthritis in mice

COURTENAY, J. S., Dallman, M. J., Dayan, A. D., Martin, A. J., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077

The endocannabinoid system and its therapeutic exploitation

Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090

Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 710

The CB2 receptor and its role as a regulator of inflammation

Turcotte, C., Blanchet, M., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 632

Cannabinoids as Novel Anti-Inflammatory Drugs

Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555

Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.

Burstein, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.059 · Cited by 573

Cannabidiol—recent advances

Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515

Cannabinoids and Pain: New Insights From Old Molecules

Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 440

Bioactive lipids, inflammation and chronic diseases

Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 376

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Fernández‐Ruíz, J., Sagredo, O., Pazos, M. R., García, C., Pertwee, R. G., Mechoulam, R., & Martínez-Orgado, J. A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04341.x · Cited by 364

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301

Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?

Croxford, J. L., & Yamamura, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.023 · Cited by 265

Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis

Rufino, A. T., Ribeiro, M. P., Sousa, C., Judas, F., Salgueiro, L., Cavaleiro, C., & Mendes, A. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.018 · Cited by 227

Cannabidiol in Humans—The Quest for Therapeutic Targets

Zhornitsky, S., & Potvin, S. (2012) · Pharmaceuticals · doi:10.3390/ph5050529 · Cited by 205

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol

Morales, P., Reggio, P. H., & Jagerovic, N. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00422 · Cited by 188

Cannabinoid Mechanisms of Pain Suppression

Walker, J. M., & Hohmann, A. G. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 177

Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function

Cabral, G. A., Rogers, T. J., & Lichtman, A. H. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9615-z · Cited by 146

Cannabinoids and autoimmune diseases: A systematic review

Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 147

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

BURSTEIN, S. H., & Zurier, R. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9084-5 · Cited by 139

Biology and therapeutic potential of cannabinoid CB2receptor inverse agonists

Lunn, C. A., Reich, E., Fine, J. S., Lavey, B. J., Kozlowski, J. A., Hipkin, R. W., Lundell, D. J., & Bober, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707480 · Cited by 120

Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids

Hanuš, L. O. (2008) · Medicinal Research Reviews · doi:10.1002/med.20135 · Cited by 117

Cannabinoids, inflammation, and fibrosis

Zurier, R. B., & BURSTEIN, S. H. (2016) · The FASEB Journal · doi:10.1096/fj.201600646r · Cited by 114

New Cannabidiol Derivatives: Synthesis, Binding to Cannabinoid Receptor, and Evaluation of Their Antiinflammatory Activity

Ben‐Shabat, S., Hanuš, L. O., Katzavian, G., & Gallily, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050709m · Cited by 108

Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production

Wu, H., Huang, C., Lin, Y., Wang, C., & Jan, T. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.023 · Cited by 105

Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors

Hanu, L. O., Tchilibon, S., Ponde, D. E., Breuer, A., Fride, E., & Mechoulam, R. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b416943c · Cited by 104

Endocannabinoids in immune regulation and immunopathologies

Rahaman, O., & Ganguly, D. (2021) · Immunology · doi:10.1111/imm.13378 · Cited by 105

Pathophysiology and treatment of pain in joint disease☆

Schaible, H., Schmelz, M., & Tegeder, I. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.011 · Cited by 98

Formation of B and T cell subsets require the cannabinoid receptor CB2

Ziring, D., Wei, B., Velázquez, P., Schrage, M. I., Buckley, N. E., & Braun, J. G. (2006) · Immunogenetics · doi:10.1007/s00251-006-0138-x · Cited by 98

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis

Fukuda, S., Kohsaka, H., Takayasu, A., Yokoyama, W., Miyabe, C., Miyabe, Y., Harigai, M., Miyasaka, N., & Nanki, T. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-275 · Cited by 93

Anti-TNF therapy: Where have we got to in 2005?

Feldmann, M., Brennan, F. M., Foxwell, B. M. J., Taylor, P. C., Williams, R. O., & Maini, R. N. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.006 · Cited by 92

The Role of Nerves in Skeletal Development, Adaptation, and Aging

Tomlinson, R. E., Christiansen, B., Giannone, A. A., & Genetos, D. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00646 · Cited by 93

Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala

Réus, G. Z., Stringari, R. B., Ribeiro, K. F., Luft, T., Abelaira, H. M., Fries, G. R., Aguiar, B. W., Kapczinski, F., Hallak, J. E., Zuardi, A. W., et al. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00579.x · Cited by 86

Ajulemic acid: A novel cannabinoid produces analgesia without a “high”

BURSTEIN, S. H., Karst, M., Schneider, U., & Zurier, R. B. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.010 · Cited by 82

Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs

Mejía, S., Duerr, F. M., Griffenhagen, G. M., & McGrath, S. (2021) · Journal of the American Animal Hospital Association · doi:10.5326/jaaha-ms-7119 · Cited by 78

Cannabinoids and Bone: Friend or Foe?

Idris, A. I., & Ralston, S. H. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9378-8 · Cited by 75

A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis

Malek, N., Mrugala, M., Makuch, W., Kolosowska, N., Przewlocka, B., Binkowski, M., Czaja, M., Morera, E., Di Marzo, V., & Starowicz, K. (2015) · Pain · doi:10.1097/j.pain.0000000000000132 · Cited by 63

The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2

Fulmer, M. L., & Thewke, D. P. (2018) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x18666180206161457 · Cited by 65

Expression of Cannabinoid Receptors in Human Osteoarthritic Cartilage: Implications for Future Therapies

Dunn, S. L., Wilkinson, J. M., Crawford, A., Bunning, R. A. D., & Le Maitre, C. L. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0001 · Cited by 62

Apoptotic vesicles ameliorate lupus and arthritis via phosphatidylserine-mediated modulation of T cell receptor signaling

Wang, R., Meng, H., Kou, X., Sui, B., Sanmillan, M. L., Zhang, X., Liu, D., Tian, J., Yu, W., Chen, C., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.026 · Cited by 61

Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice

Jan, T., Su, S.-T., Wu, H., & Liao, M.-H. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.01.015 · Cited by 61

Involvement of the endocannabinoid system in osteoarthritis pain

Porta, C. L., Bura, S. A., Negrete, R., & Maldonado, R. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12468 · Cited by 61

Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction

Robinson, R. H., Meissler, J. J., Deckman, J. M., Gaughan, J. P., Adler, M. W., & Eisenstein, T. K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9485-1 · Cited by 60

Pain measurements and side effect profile of the novel cannabinoid ajulemic acid

Salim, K., Schneider, U., Burstein, S., Hoy, L., & Karst, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.010 · Cited by 58

Lipids as targets for novel anti-inflammatory therapies

Huwiler, A., & Pfeilschifter, J. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.008 · Cited by 60

Joints for joints: cannabinoids in the treatment of rheumatoid arthritis

Lowin, T., Schneider, M., & Pongratz, G. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000590 · Cited by 55

The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice

Sophocleous, A., Börjesson, A. E., Salter, D. M., & Ralston, S. H. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.04.020 · Cited by 54

Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier

Scheau, C., Căruntu, C., Bădărău, I. A., Scheau, A.-E., Docea, A. O., Călina, D. C., & Căruntu, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060494 · Cited by 54

The endocannabinoid system and its therapeutic implications in rheumatoid arthritis

Gui, H., Tong, Q., Qu, W., Mao, C.-M., & Dai, S. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.006 · Cited by 56

Selective breeding for dominant and submissive behavior in Sabra mice

Feder, Y., Nesher, E., Ogran, A., Kreinin, A., Malatyńska, E., Yadid, G., & Pinhasov, A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.018 · Cited by 54

An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives

Wang, X., Zhang, H., Liu, Y., Yang, X., Yang, B., Li, H., & Chen, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106810 · Cited by 57

Blockade of NKG2D ameliorates disease in mice with collagen‐induced arthritis: A potential pathogenic role in chronic inflammatory arthritis

Andersson, A. K., Sumariwalla, P. F., McCann, F. E., Amjadi, P., Chang, C., McNamee, K., Tornehave, D., Haase, C., Agersø, H., Stennicke, V. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30460 · Cited by 50

Therapeutic Potential of Cannabinoid-Based Drugs

Klein, T., & Newton, C. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_43 · Cited by 49

Synthetic Strategies for (−)‐Cannabidiol and Its Structural Analogs

Jung, B., Lee, J. K., Kim, J., Kang, E. K., Han, S. Y., Lee, H., & Choi, I. S. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201901179 · Cited by 48

Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes

Dunn, S. L., Wilkinson, J. M., Crawford, A., Le Maitre, C. L., & Bunning, R. A. D. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.10.016 · Cited by 46

Potential anti-inflammatory actions of the elmiric (lipoamino) acids

BURSTEIN, S. H., Adams, J. K., Bradshaw, H. B., Fraioli, C., Rossetti, R. G., Salmonsen, R. A., Shaw, J. W., Walker, J. M., Zipkin, R. E., & Zurier, R. B. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.03.026 · Cited by 46

The Current and Potential Application of Medicinal Cannabis Products in Dentistry

Lowe, H. I. C., Toyang, N. J., Steele, B., Bryant, J., Ngwa, W. F., & Nedamat, K. (2021) · Dentistry Journal · doi:10.3390/dj9090106 · Cited by 51

Activation of cannabinoid receptors prevents antigen‐induced asthma‐like reaction in guinea pigs

Giannini, L., Nistri, S., Mastroianni, R., Cinci, L., Vannacci, A., Mariottini, C., Passani, M. B., Mannaioni, P. F., Bani, D., & Masini, E. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00258.x · Cited by 45

Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials

Burstein, S. (2005) · The AAPS Journal · doi:10.1208/aapsj070115 · Cited by 44

Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases

Mesa, X. M. R., Vergara, A. F. M., Bolaños, L. A. C., Guevara-Moriones, N., Piñeros, A. L. M., & González, S. P. S. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0183 · Cited by 43

Cannabimimetic Properties of Ajulemic Acid

Vann, R. E., Cook, C. D., Martin, B. R., & Wiley, J. L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111625 · Cited by 41

Electroacupuncture potentiates peripheral CB2 receptor-inhibited chronic pain in a mouse model of knee osteoarthritis

Yuan, X., Wang, Q., Su, W., Li, H., Wu, C., Gao, F., Xiang, H.-C., Zhu, H., Lin, L., Hu, X., et al. (2018) · Journal of Pain Research · doi:10.2147/jpr.s171664 · Cited by 41

Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease

Gentili, M., Ronchetti, S., Ricci, E., Paola, R. D., Gugliandolo, E., Cuzzocrea, S., Bereshchenko, O., Migliorati, G., & Riccardi, C. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.005 · Cited by 37

Endocannabinoids and liver disease – review

Gabbay, E., Avraham, Y., Ilan, Y., Israeli, E., & Berry, E. M. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01180.x · Cited by 38

Cannabinoids in pain and inflammation

Mbvundula, E. C., Rainsford, K. D., & Bunning, R. A. D. (2004) · Inflammopharmacology · doi:10.1163/1568560041352275 · Cited by 36

Marijuana Use and Brain Immune Mechanisms

Cabral, G. A., & Jamerson, M. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00008-7 · Cited by 34

Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies

Veiga, M., Azevedo‐Silva, J., & Fernandes, J. C. (2023) · Pharmaceuticals · doi:10.3390/ph16020155 · Cited by 36

Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells

Stebulis, J. A., Johnson, D. R., Rossetti, R. G., BURSTEIN, S. H., & Zurier, R. B. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.09.004 · Cited by 34

Medical cannabis and cannabinoids in rheumatology: where are we now?

Sarzi‐Puttini, P., Batticciotto, A., Atzeni, F., Bazzichi, L. M., Franco, M. D., Salaffi, F., Marotto, D., Ceribelli, A., Ablin, J. N., & Häuser, W. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1665997 · Cited by 34

Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model

Andersson, C., Wenander, C. S., Usher, P. A., Hebsgaard, J. B., Søndergaard, B. C., Rønø, B., Mackay, C. R., Friedrichsen, B. N., Chang, C., Tang, R., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12338 · Cited by 32

Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity

Kogan, N. M., Lavi, Y., Topping, L. M., Williams, R. O., McCann, F. E., Yekhtin, Z., Feldmann, M., Gallily, R., & Mechoulam, R. (2021) · Molecules · doi:10.3390/molecules26185601 · Cited by 32

Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain

Mitchell, V. A., Aslan, S. C., Safaei, R., & Vaughan, C. W. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.019 · Cited by 31

Cannabidiol induced a contrasting pro-apoptotic effect between freshly isolated and precultured human monocytes

Wu, H.-Y., Chang, A.-C., Wang, C., Kuo, F.-H., Lee, C.-Y., Liu, D.-Z., & Jan, T. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.05.003 · Cited by 31

Cannabinoids in the treatment of rheumatic diseases: Pros and cons

Sarzi‐Puttini, P., Ablin, J. N., Trabelsi, A., Fitzcharles, M., Marotto, D., & Häuser, W. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102409 · Cited by 31

Comparative Analysis of the Behavioral and Biomolecular Parameters of Four Mouse Strains

Nesher, E., Peskov, V., Rylova, A., Raz, O., & Pinhasov, A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9544-0 · Cited by 27

Cannabidiol as an immune modulator: A comprehensive review

Mujahid, K., Rasheed, M. S., Sabir, A., Nam, J., Ramzan, T., Ashraf, W., & Imran, I. (2025) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00005-7 · Cited by 31

HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid

Haj, C. G., Sumariwalla, P. F., Hanuš, L., Kogan, N. M., Yektin, Z., Mechoulam, R., Feldmann, M., & Gallily, R. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226100 · Cited by 26

Cannabinoids in the Management of Musculoskeletal Pain

Madden, K., van der Hoek, N., Chona, S., George, A., Dalchand, T., Baldawi, H., Mammen, G., & Bhandari, M. (2018) · JBJS Reviews · doi:10.2106/jbjs.rvw.17.00153 · Cited by 25

Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective

Karst, M., & Wippermann, S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802691951 · Cited by 24

The cannabinoid acids, analogs and endogenous counterparts

BURSTEIN, S. H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.03.038 · Cited by 23

Anti‐Inflammatory, Antioxidative, and Hepatoprotective Effects of Trans Δ9‐Tetrahydrocannabinol/Sesame Oil on Adjuvant‐Induced Arthritis in Rats

Ismail, M., Hasan, H. A., El-Orfali, Y., Ismail, H. F., & Khawaja, G. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/9365464 · Cited by 22

Preclinical science regarding cannabinoids as analgesics: An overview

Lynch, M. (2005) · Pain Research and Management · doi:10.1155/2005/169093 · Cited by 20

Do cannabinoids have a therapeutic role in transplantation?

Nagarkatti, M., Rieder, S. A., Hegde, V. L., Kanada, S., & Nagarkatti, P. S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.05.006 · Cited by 20

Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum

BURSTEIN, S. H. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000083 · Cited by 19

Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions

Paland, N., Hamza, H., Pechkovsky, A., Aswad, M., Shagidov, D., & Louria‐Hayon, I. (2023) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10509 · Cited by 28

Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases

Quezada, S. M., & Cross, R. K. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0670-0 · Cited by 19

Cannabinoids: Novel Therapies For Arthritis?

Dunn, S. L., Wilkinson, J. M., Crawford, A., Maitre, C. L. L., & Bunning, R. A. D. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.20 · Cited by 18

Cannabidiol and Other Cannabinoids in Demyelinating Diseases

Navarrete, C. M., García‐Martín, A., Rolland, A. P., DeMesa, J., & Muñóz, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062992 · Cited by 20

Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis

Petrella, C., Agostini, S., Alemà, G., Casolini, P., Carpino, F., Giuli, C., Improta, G., Linari, G., Petrozza, V., & Broccardo, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01569.x · Cited by 18

Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review

Xin, Y., Tang, A., Pan, S., & Zhang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.793750 · Cited by 18

Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice

Delsing, D. J. M., Leijten, F. P., Arts, K., van Eenennaam, H., Garritsen, A., Gijbels, M. J., de Winther, M. P. J., & van Elsas, A. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010015 · Cited by 17

Pathophysiology of Portal Hypertension

Morales‐Ruiz, M., Rodríguez‐Vita, J., Ribera, J., & Jiménez, W. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_144 · Cited by 17

Cannabinoids in Periodontology: Where Are We Now?

Rendón, Y. A. C., Garzon, H. S., Bueno‐Silva, B., Arce, R. M., & Suárez, L. J. (2023) · Antibiotics · doi:10.3390/antibiotics12121687 · Cited by 19

Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease

Gusho, C., & Court, T. (2020) · Cureus · doi:10.7759/cureus.7375 · Cited by 16

Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs (Cavia porcellus)

Spittler, A. P., Helbling, J. E., McGrath, S., Gustafson, D. L., Santangelo, K. S., & Sadar, M. J. (2021) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.13026 · Cited by 16

Endocannabinoids in arthritis: current views and perspective

Barrie, N., Kuruppu, V., Manolios, E., Ali, M., Moghaddam, M. J., & Manolios, N. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13146 · Cited by 15

Complementary and Alternative Medicine

Quezada, S. M., Briscoe, J. A., & Cross, R. K. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000761 · Cited by 15

Cannabinoid chemistry: an overview

Hanuš, L. O., & Mechoulam, R. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_2 · Cited by 13

Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin- and AMPKα-independent manner

Alpert, E., Gruzman, A., Lardi‐Studler, B., Cohen, G., Reich, R., & Sasson, S. (2006) · Diabetologia · doi:10.1007/s00125-005-0122-2 · Cited by 13

Cannabis for Rheumatic Disease Pain: a Review of Current Literature

Nowell, W. B., Gavigan, K., & Silverman, S. L. (2022) · Current Rheumatology Reports · doi:10.1007/s11926-022-01065-7 · Cited by 15

Cannabinoids in Models of Chronic Inflammatory Conditions

Mechoulam, R., Sumariwalla, P. F., Feldmann, M., & Gallily, R. (2005) · Phytochemistry Reviews · doi:10.1007/s11101-004-1534-1 · Cited by 11

Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis

Gui, H., Liu, X., Liu, L.-R., Su, D.-F., & Dai, S.-M. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.12.012 · Cited by 60

HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid

Haj, C. G., Sumariwalla, P. F., Hanuš, L., Kogan, N. M., Yektin, Z., Mechoulam, R., Feldmann, M., & Gallily, R. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226100 · Cited by 26

Suppression of human monocyte interleukin-1β production by ajulemic acid, a nonpsychoactive cannabinoid

Zurier, R. B., Rossetti, R. G., BURSTEIN, S. H., & Bidinger, B. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01604-0 · Cited by 62

Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between Treg and Th17 cells

Tian, N., Yang, C., Du, Y. L., Chen, M., Li, B., Li, D., & Dai, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1532518 · Cited by 8